NK Cell Therapy for Solid Tumors from Japan
NK cell therapy involves natural killer cells from peripheral blood that are cytokine-activated and expanded for adoptive transfer in treating solid tumors like melanoma. These modified cell cultures are classified as cell therapy products under tariff item 3002.51.00.
Duty Rate — Japan → Canada
0%
Import Tips
• Check if the product requires a Health Canada authorization under the Food and Drug Regulations, as cell therapies are biologics
• Provide a detailed description of the activation and expansion process to the CBSA
• Ensure that all import documentation is in English or French to avoid delays